Rigel Pharmaceuticals, Inc. (RIGL)
37.80
-1.32
(-3.37%)
USD |
NASDAQ |
Jan 15, 16:00
37.75
-0.05
(-0.13%)
After-Hours: 20:00
Rigel Pharmaceuticals SG&A Expense (TTM): 115.43M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Nektar Therapeutics | 74.62M |
| Ironwood Pharmaceuticals, Inc. | 96.29M |
| Catalyst Pharmaceuticals, Inc. | 162.44M |
| Perspective Therapeutics, Inc. | 31.53M |
| Vertex Pharmaceuticals, Inc. | 1.644B |